Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy

被引：0
|
作者：
Ghidini, M. [1 ]
Hahne, J. C. [2 ]
Senti, C. [3 ]
Tomasello, G. [1 ]
Ratti, M. [3 ]
Heide, T. [4 ]
Garrone, O. [1 ]
Cortellini, A. [5 ]
Passalacqua, R. [3 ]
Valeri, N. [5 ]
机构：
[1] Fdn IRCCS Osped Maggiore Policlin, Oncol Unit, Milan, Italy
[2] ICR, Ctr Mol Pathol, London, England
[3] ASST Cremona Azienda Sociosanitaria Terr, Oncol Unit, Cremona, Italy
[4] Human Technopole, Computat Biol Res Ctr, Milan, Italy
[5] Imperial Coll London, Dept Surg & Canc, London, England
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1355
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2326P
引用
收藏
页码：S1188 / S1188
页数：1
相关论文
共 50 条
  • [31] Circulating tumor DNA (ctDNA) in metastatic melanoma (MM) patients (pts) with brain metastases (mets).
    Lee, Jenny H. J.
    Menzies, Alexander M.
    Carlino, Matteo S.
    Kefford, Richard
    Scolyer, Richard A.
    Long, Georgina V.
    Rizos, Helen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Clinical utility of circulating tumor DNA (ctDNA) in advanced and metastatic breast cancer
    Austin, Laura K.
    Jaslow, Rebecca
    Avery, Tiffany
    Fortina, Paolo
    Sebisanovic, Dragan
    Siew, LaiMun
    Zapanta, Aubrey
    Talasaz, AmirAli
    Cristofanilli, Massimo
    CANCER RESEARCH, 2015, 75
  • [33] Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer
    Nakamura, Yoshiaki
    Yoshino, Takayuki
    ONCOLOGIST, 2018, 23 (11): : 1310 - 1318
  • [34] Circulating tumor (ct) DNA captures intrapatient heterogeneity in metastatic colorectal (mCRC) patients (pts) progressing to FOLFIRI plus panitumumab
    Vidal, J.
    Vieitez, J. M.
    Paez, D.
    Santos, C.
    Falco, E.
    Lopez Lopez, C.
    Valladares-Ayerbes, M.
    Robles, L.
    Garcia-Alfonso, P.
    Duran Ogaya, G.
    Azuara, D.
    Dalmeses, A.
    Bellosillo Paricio, B.
    Capella, G.
    Salazar, R.
    Aranda Aguilar, E.
    Montagut, C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [35] Circulating tumor DNA (ctDNA) in metastatic uveal melanoma (MUM): Correlation with outcome in 87 patients (pts) from Institut Curie
    Piperno-Neumann, S.
    Madic, J.
    Mariani, P.
    Rampanou, A.
    Servois, V.
    Bidard, F. C.
    Milder, M.
    Cassoux, N.
    Desjardins, L.
    Stern, M. H.
    Lantz, O.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [36] Gene mutation status in circulating tumor DNA (ctDNA) and first-line FOLFOXIRI plus bevacizumab (bev) in metastatic colorectal cancer (mCRC) harboring RAS mutation
    Sunakawa, Y.
    Usher, J.
    Satake, H.
    Jaimes, Y.
    Miyamoto, Y.
    Nakamura, M.
    Kataoka, M.
    Shiozawa, M.
    Takagane, A.
    Terazawa, T.
    Watanabe, T.
    Ishigure, K.
    Tanaka, C.
    Sekikawa, T.
    Takeuchi, M.
    Fujii, M.
    Danenberg, K.
    Danenberg, P. V.
    Lenz, H-J.
    Ichikawa, W.
    ANNALS OF ONCOLOGY, 2018, 29
  • [37] Analysis of biomarkers in circulating tumor DNA from the phase 3 CONCUR study of regorafenib in Asian patients with metastatic colorectal cancer (mCRC): Correlation with clinical outcome
    Teufel, M.
    Kalmus, J.
    Rutstein, M.
    Koechert, K.
    Seidel, H.
    Reischl, J.
    Skubula, A.
    Vonk, R.
    Wilhelm, S.
    Kobina, S.
    Qin, S.
    Xu, R.
    Kim, T. W.
    Li, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S332 - S332
  • [38] Circulating tumor DNA fraction (ctDNA%) to independently predict for clinical outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Maurice-Dror, Corinne
    Fonseca, Nicolette
    Herberts, Cameron
    Fan, William
    Wyatt, Alexander W.
    Chi, Kim N.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] Circulating tumor DNA (ctDNA) dynamics in response to checkpoint inhibitor immunotherapy in colorectal cancer
    Patell, Kanchi
    Kurian, Matthew
    Booker, Benjamin
    Chung, Michelle
    Bennett, Alexis
    Bajor, David L.
    Mohamed, A. M. R.
    Mahipal, Amit
    Chakrabarti, Sakti
    Selfridge, J. Eva
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] RAS mutations concordance in circulating tumor DNA (ctDNA) and tissue in metastatic colorectal cancer (mCRC): RASANC, an AGEO prospective multicenter Study.
    Bachet, Jean-Baptiste
    Bouche, Olivier
    Taieb, Julien
    Dubreuil, Olivier
    Garcia, Marie-Line
    Meurisse, Aurelia
    Gornet, Jean-Marc
    Artru, Pascal
    Louafi, Samy
    Soularue, Emilie
    Baumgaertner, Isabelle
    Coriat, Romain
    Tougeron, David
    Lecomte, Thierry
    Mary, Florence
    Marthey, Lysiane
    Blons, Helene
    Taly, Valerie
    Bonnetain, Franck
    Laurent-Puig, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345